Alta Charo, a UW-Madison law and bioethics professor, said patients might not realize that stem cell injections from umbilical cord tissue are different from bone marrow transplants — which are approved and have been performed for decades — and experimental therapies using embryonic or induced pluripotent stem cells, for which clinical trials are in early stages or have not begun.